secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001193125-23-135011
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q3 revenue +13% to $50.5B; raises FY23 non-GAAP EPS guidance to $5.60-$5.80
--------------------------------------------------------------------------------

- Revenue $50.5B (+13% YoY); GAAP EPS $1.34 (vs -$5.05 loss); Non-GAAP EPS $1.74 (+20% YoY).
- Pharmaceutical segment profit $600M (+23%); Medical segment profit $20M (-66%).
- FY23 non-GAAP EPS guidance raised to $5.60-$5.80 from $5.20-$5.50; adjusted FCF raised to $2.0-$2.3B.
- Cooperation agreement with Elliott extended to July 15, 2024; Business Review Committee extended similarly.
- Pharmaceutical profit growth outlook raised to 10.5%-12%; Medical profit outlook lowered to ~50% decline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/0001193125-23-135011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/d358353d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-135011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer